Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Librera OncoLink / Repaso de Diarios / Cáncer de Cérvix
|
A Randomized Trial of Pelvic Radiation Therapy Versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study
Reviewers: John Han-Chih Chang, MD Background / Discussion / Critique Early stage cervical cancer has a very good prognosis treated with either surgery (radical hysterectomy - RH) or radiation therapy (RT). The standard of care has been radical... |
|
|
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Reviewers: Kenneth Blank, MDSource: New England Journal of Medicine April 15, 1999IntroductionThe treatment of women with locally advanced cervical cancer is evolving. Radiotherapy and chemotherapy form the standard of care in the United States;... |
|
|
Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Reviewers: Li Liu, MDSource: Journal of Clinical Oncology, 17(9): 2676, September 1999BackgroundThis is a phase II study testing the efficacy and toxicity of paclitaxel and cisplatin in recurrent or advanced squamous cell carcinoma of the cervix. It... |
|
|
PAPNET-Assisted Re-screening of Cervical Smears - Cost and Accuracy Compared with a 100% Manual Re-screening Strategy
Reviewers: John Han-Chih Chang, MD and Kenneth Blank, MD Source: gynecological cancer screening. It can detect cervical cancer along with vaginal and endometrial malignancies. It has reduced the cancer-associated mortality in cervical cancer,... |
|
|
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
Reviewers: Kenneth Blank, MDSource: RTOG) to conduct a large randomized prospective trial of radiotherapy alone versus combined radiotherapy andchemotherapy.The results of this trial will be reported in the April 15, 1999 issue ofthe New England... |
|
|
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
Authors: Morris M, Eifel P, Jiandong L, et al. Source: N Engl J Med 1999; 340:1137-1143. Background Cervical cancers that are bulky, extend to parametrial/pelvic tissues and/or involve pelvic lymph nodes benefit from external-beam plus... |
|
|
Randomized Comparison Of Fluorouracil Plus Cisplatin Versus Hydroxyurea As An Adjunct To Radiation Therapy In Stage IIB-IVA Carcinoma Of The Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group And Southwest Oncology Group Study
Reviewers: John Han-Chih Chang, MD Source: Conclusion: This study demonstrates that for patients with locally advanced carcinoma of the cervix, the combination of 5-FU and CF with RT offers patients better PFS and overall survival than HU, and... |
|
|
Randomized Comparison of Weekly Cisplatin or Protracted Venous Infusion of Fluorouracil in Combination with Pelvic Radiation in Advanced Cervix Cancer: A GOG study
Source: J Clin Oncol. 2005 Nov 20;23(33):8289-95 Authors: Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA 3rd, Moore DH, Monk BJ, O'Connor DM. Background Concurrent chemoradiation is the standard of care in locally advanced cervical... |
|
|
Vaginal Changes and Sexuality in Women with a History of Cervical Cancer
Reviewers: Kenneth Blank, MD Source: New England Journal of Medicine, May 6, 1999 Vol. 340 No. 18 p. 1383IntroductionLocal treatment of cervical cancer often involves surgery, radiotherapy, or a combination of both treatments. For early stage... |
Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

